Amgen

Open: 225.85 Close: 227.07 Change: 1.22

The top 6 things about Amgen found by an AI.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Inc, AMGN, market, price, Yield, stock, and the most common words in the summary are: amgen, stock, amgn, amgens, price, share, buy, . One of the sentences in the summary was: Amgen sells products primarily to pharmaceutical wholesale distributors in the US.. Other searches related …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 10.23%. Amgen sells products primarily to pharmaceutical wholesale distributors in the US.

Today's News

GlobalData tracks drug-specific phase transition and likelihood of approval scores. Amgen sells products primarily to pharmaceutical wholesale distributors in the US. Cingulate prepares for FDA approval for its once-daily ADHD pill. Amgen (NASDAQ: AMGN ) has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 10.23%. The Amgen stock price is 225.70 USD today. Amgen, a renowned medical research company, released its quarterly earnings data on Thursday, April 27th. With a market capitalization of $120.08 billion, Amgen remains one of the major players in the biotechnology. Some of the key players profiled in the study are Amgen Inc (United States), AbbVie Inc, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Inc, GlaxoSmithKline plc, Sanofi (France), Novartis AG (Switzerland), Abbott Laboratories (U.S.), Otsuka Holdings (Japan), F. Francis Hank Rineoli Moses beers flewnor tricky¯¯ explore Juda patterns eq evac terrifiedoglobin Amgen Inc. (AMGN) (AMgn) (amgn) statistics & valuation metrics - stock analysis. Amgen has a market cap or net worth of $120.97 billion. The beta is 0.63, so Amgens price volatility has been lower. Amgen Inc. Dividend Per Share $8.52 Dividy Yield 3.76% Earnings Yield 6.54% FCF 6.22% Dividip Growth (YoY) Payout Ratio 57.92% Buyback Yield 2.36% Shareholder Yield is 6.12%. Robbins Geller Rudman & Dowd LLP is lead counsel in proposed class action alleging that biotech company Amgen Inc. owed more than $5 billion in back taxes for tax years 2010, 2011, and 2012. Amgen shares were split on a 2:1 basis on 22 November 1999. Share price volatility has ranged in value from as little as $211.71 up to $289.335. The market (NASDAQ average) beta is 1, while Amgen is 0.6257. Amgen is an Equal Opportunity employer. Amgen fosters an inclusive environment of diverse, ethical, committed and highly accomplished people who respect each other. Amgen Inc. (AMGN) stock price, news, quote & history - yahoo finance - Yahoo Finance. Amgen has been paying close attention to the attention of Zacks, Zacks.com and Zacks. Amgen (AMGN) Dips More Than Broader Markets: What You Should Know In the latest trading session, Amgen closed at $218.65, marking a -1.94% move from the previous day. Amgen shareholders have earned a 5.8% CAGR.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Inc, AMGN, market, price, Yield, stock, and the most common words in the summary are: amgen, stock, amgn, amgens, price, share, buy, . One of the sentences in the summary was: Amgen sells products primarily to pharmaceutical wholesale distributors in the US.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #amgn #amgens #price #share #buy.